Analyst Price Target is $3.25
▲ +828.57% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Arcadia Biosciences in the last 3 months. The average price target is $3.25, with a high forecast of $3.50 and a low forecast of $3.00. The average price target represents a 828.57% upside from the last price of $0.35.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in Arcadia Biosciences. This Buy consensus rating has held steady for over two years.
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was incorporated in 2002 and is headquartered in Davis, California.